OpGen is a precision medicine company that develops and commercializes molecular microbiology solutions, including in vitro diagnostic tests for the detection and identification of bacterial nucleic acids and genetic determinants of antimicrobial resistance. The company's products also include automated sample-to-answer molecular diagnostics platforms and bioinformatics solutions for antibiotic response prediction. OpGen collaborates with healthcare institutions to detect, track, and manage antimicrobial-resistant infections. The company is headquartered in Rockville, Maryland.